Stock screener

OCUL

Conviction 33HealthcareScan · Thu, Sep 24, 2026
Hammer

Ocular Therapeutix, Inc (OCUL) closed at $9.83 (-1.70%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 44, RS Rating 30, -39.0% from its 52-week high, -16.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

OCUL$9.83-1.70%
ResistanceSupportVol 14Insider sell
63 bars
4
Vol MA14 2.53M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
OCULAR THERAPEUTIX, INCPHARMACEUTICAL PREPARATIONSwww.ocutx.com ↗
Price9.83
Change-1.70%
Gap-0.70%
Rel volume1.50×
Avg volume2.28M
Avg $ vol23.83M
SMA 2010.48
SMA 509.88
SMA 2009.85
Price vs 50-0.50%
Price vs 200-0.16%
MA stackmixed
50/200 crossgolden · 2d
Supertrendup · 9.76
RSI (14)44
MACD hist-0.12
MACD cross—
Stoch %K / %D12 / 22
ADX (14)15
+DI / −DI20 / 23
RSI divergence—
MACD divergence—
ATR %5.57%
ADR %5.14%
52w high16.11
52w low6.88
From 52w high-38.98%
Above 52w low+42.88%
New 52w highNo
SqueezeOff
Bollinger width16.90%
%B0.13
Donchian pos12.23%
Donchian high11.48
Donchian low9.60
AVWAP (52w high)9.78
vs AVWAP high+0.50%
AVWAP (52w low)9.07
vs AVWAP low+8.41%
OBV trendFlat
Chaikin MF (20)-0.06
Today vs 20d1.50×
Avg vol (14d)2.53M
Avg vol (20d)2.28M
Avg $ vol (20d)23.83M
Market cap2.16B
RS Rating30 / 99
RS 3m (vs SPY)-3.77%
RS 6m (vs SPY)+1.19%
RS line new highNo
Trend template1/8
Technical rank57.2
1 week-3.06%
1 month-9.65%
3 months+0.72%
6 months+18.01%
1 year-19.76%
YTD-16.84%
P/E-8.12
P/B4.15
P/S41.55
P/FCF-9.95
EPS-1.42
Div yield—
ROE-51.14%
ROA-39.61%
Debt/Eq0.03
Current13.11
EV/EBITDA-5.94
Gross margin—
Net margin-511.90%
Rev growth-18.47%
EPS growth-37.43%
Price target25.25
Target upside156.87%
Analyst ratingBuy
Institutional100.19%
Ent. value1.58B
Revenue13.47M
Net income-78.76M
Gross profit—
Free cash flow-216.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out218.96M
Employees325
ListedFri, Jul 25, 2014
Free float179.1M
Float %82.3%
Short interest28.06M
Days to cover9.0d
Short volume54.5%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.35 vs −$0.40
Last surprise+12.5% beat
Setup gradeD
Conviction33 / 100
Pattern quality—
Tech rank57.2 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OCUL

All disclosures →
No recent disclosed trades by Congress in OCUL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OCUL · open-market 6 sells

InsiderSideShares
Notman Donald
Chief Operating Officer · Common Stock · 2026-08-31
Sell1.1K
Dugel Pravin
See Remarks · Common Stock · 2026-08-25
Gift50.09K
Dugel Pravin
See Remarks · Common Stock · 2026-08-25
Gift50.09K
Nayak Sanjay
Chief Strategy Officer · Common Stock · 2026-08-24
Sell1.9K
Heier Jeffrey S.
Chief Scientific Officer · Common Stock · 2026-08-24
Sell3.3K
Dugel Pravin
See Remarks · Common Stock · 2026-08-24
Sell21.65K
Kaiser Peter
Chief Development Officer · Common Stock · 2026-08-24
Sell3.04K
Dugel Pravin
See Remarks · Common Stock · 2026-06-16
Gift50.09K
Dugel Pravin
See Remarks · Common Stock · 2026-06-16
Gift50.09K
Waheed Nadia
Chief Medical Officer · Common Stock · 2026-06-03
Sell14.83K

SEC filings

EDGAR filings in OCUL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.